M Moriau
About
In The Last Decade
M Moriau
42 papers receiving 617 citations
Peers
Comparison fields: 5 of 78
- Hematology 249
- Surgery 231
- Cardiology and Cardiovascular Medicine 121
- Internal Medicine 95
- Pulmonary and Respiratory Medicine 92
Countries citing papers authored by M Moriau
This map shows the geographic impact of M Moriau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Moriau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Moriau more than expected).
Fields of papers citing papers by M Moriau
This network shows the impact of papers produced by M Moriau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Moriau. The network helps show where M Moriau may publish in the future.
Co-authorship network of co-authors of M Moriau
This figure shows the co-authorship network connecting the top 25 collaborators of M Moriau. A scholar is included among the top collaborators of M Moriau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Moriau. M Moriau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases | Thrombosis Research | Pierre Hainaut, David Verhelst et al. | 30 |
| 2 | The Prothrombin Gene G20210A Variant in an Unselected Thromboembolic Population. A belgian prospective clinical study. | Acta Clinica Belgica | Jean‐Luc Gala, E. Lavenne et al. | 4 |
| 3 | Prevalence of activated protein C resistance and analysis of clinical profile in thromboembolic patients. A Belgian prospective study | Journal of Internal Medicine | Pierre Hainaut, F. Lehmann et al. | 11 |
| 4 | Case 5—1996 thrombosis after the use of a heparin-coated cardiopulmonary bypass circuit in a patient with heparin-induced thrombocytopenia | Journal of Cardiothoracic and Vascular Anesthesia | E Lavenne-Pardonge, M Moriau et al. | 3 |
| 5 | ACQUIRED ACTIVATED PROTEIN C RESISTANCE IN PREGNANCY | Thrombosis Research | M Moriau, E Lavenne-Pardonge et al. | 16 |
| 6 | The treatment of severe or recurrent deep venous thrombosis | Thrombosis Research | M Moriau, E Lavenne-Pardonge et al. | 8 |
| 7 | Hydroxyethylrutosides in Elderly Patients with Chronic Venous Insufficiency: Its Efficacy and Tolerability | Gerontology | J. A. Wilson, M Moriau et al. | 22 |
| 8 | Platelet anti-aggregant and rheological properties of piracetam. A pharmacodynamic study in normal subjects. | PubMed | M Moriau, E Lavenne-Pardonge et al. | 30 |
| 9 | A novel preservation medium protecting prostacyclin production and endothelial integrity of the human saphenous vein graft | Thrombosis Research | Robert Dion, E Lavenne-Pardonge et al. | 12 |
| 10 | Pharmacokinetics, thrombolytic efficacy and hemorrhagic risk of different streptokinase regimens in heparin-treated acute myocardial infarction | The American Journal of Cardiology | Jacques Col, Jean Renkin et al. | 6 |
| 11 | 182 Anticoagulant and fibrinolytic effects of ionic contrast media in man | Fibrinolysis and Proteolysis | E Lavenne-Pardonge, John B. Etienne et al. | 1 |
| 12 | COMPARATIVE FIBRINOLYTIC ACTIVITY AND THROMBOLYTIC EFFICACY OF APSAC WITH VARIOUS REGIMENS OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION | Thrombosis and Haemostasis | E Lavenne-Pardonge, M Moriau et al. | 1 |
| 13 | Abo-incompatible Related and Unrelated Living Donor Renal-allografts | Transplantation Proceedings | Guy P. Alexandre, Yves Pirson et al. | 18 |
| 14 | Splenectomy As a Prerequisite for Successful Human Abo-incompatible Renal-transplantation | Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) | Guy P. Alexandre, Yves Pirson et al. | 67 |
| 15 | Plasma-exchange in Waldenstroms Disease - Efficacy and Comparison of Continuous Centrifugation, Discontinuous Centrifugation, and Filtration | Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) | André Bosly, Bernard Châtelain et al. | 2 |
| 16 | Clinical and Biological Activity of the Antiplatelet Agent Suloctidil in Treatment of Idiopathic Recurrent Vein Thrombosis (I.R.V.T.) | Thrombosis and Haemostasis | M Moriau, Augustin Ferrant et al. | 8 |
| 17 | Evaluation of the Antithrombotic Properties of Suloctidil in Patients with Substitute Heart Valves | Thrombosis and Haemostasis | M Moriau, Augustin Ferrant et al. | 1 |
| 18 | Comparative Effects of Dextrans, Gelatin and Stable Plasma Protein Solution (SPPS) on the Experimental Disseminated Intravascular Coagulation (DIC) | Vox Sanguinis | M Moriau, J Rodhain et al. | 6 |
| 19 | Successful Orthotopic Transplantation of the Canine Liver after Prolonged Preservation by Initial Perfusion and Cold Storage | European Surgical Research | Jean-Bernard Otte, Luc Lambotte et al. | 4 |
| 20 | Les inhibiteurs de la fibrinolyse et le dosage de l’activité antiplasminique physiologique et pathologique | Thrombosis and Haemostasis | M Moriau et al. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.